Literature DB >> 1401195

PIVKA-II concentrations in patients with cystic fibrosis.

E A Cornelissen, A F van Lieburg, C G van Oostrom, L Monnens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1401195      PMCID： PMC495164          DOI： 10.1136/jcp.45.8.742-a

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  9 in total

1.  Increased PIVKA-II concentrations in patients with cystic fibrosis.

Authors:  M de Montalembert; G Lenoir; A Saint-Raymond; J Rey; J J Lefrère
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

2.  Coagulation abnormalities in cystic fibrosis.

Authors:  D M Komp; R F Selden
Journal:  Chest       Date:  1970-11       Impact factor: 9.410

3.  Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II).

Authors:  J Widdershoven; P van Munster; R De Abreu; H Bosman; T van Lith; M van der Putten-van Meyel; K Motohara; I Matsuda
Journal:  Clin Chem       Date:  1987-11       Impact factor: 8.327

4.  Elevation of different des-gamma-carboxyproteins in hepatocellular carcinoma.

Authors:  J J Lefrère; P Van Dreden; M Samama
Journal:  Thromb Haemost       Date:  1987-12-18       Impact factor: 5.249

5.  Des-gamma-carboxyprothrombin and hepatoblastoma.

Authors:  J J Lefrere; D Armengaud; M Leclerq; M Guillaumont; D Gozin; D Alagille
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

6.  Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins.

Authors:  H Bechtold; K Andrassy; E Jähnchen; J Koderisch; H Koderisch; L S Weilemann; H G Sonntag; E Ritz
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

7.  The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin.

Authors:  G L Nelsestuen; T H Zytkovicz; J B Howard
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

8.  A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.

Authors:  J P Soulier; D Gozin; J J Lefrere
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

9.  Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

Authors:  H A Liebman; B C Furie; M J Tong; R A Blanchard; K J Lo; S D Lee; M S Coleman; B Furie
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.